Associate Professor Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J8-33
- Telephone
- 0104088567
- hakkaart@eshpm.eur.nl
More information
‹ Back to overview
Profile
Leona Hakkaart studied economics at the Erasmus University Rotterdam from 1984 to 1989. Between 1990 and 1994 she was employed at the Department of Public Health at the Erasmus University Rotterdam. She worked on the first general cost of illness study for the Netherlands and the methodology of measuring production losses from paid and unpaid employment. From 1995 she has been employed at the institute for Medical Technology assessment as a health economist. She has been involved in many cost-of-illness and cost-effectiveness studies for a number of diseases. Furthermore, she developed the Health and Labour Questionnaire (HLQ) a frequently applied tool for measuring production losses due to illness or its treatment in economic evaluations. In 1998 she completed here thesis entitled: 'Societal perspective on the cost of illness'. Since a few years she has specialised in the area of mental health and dermatology. In co-operation with the Trimbos institute she developed the ‘Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness' (TiC-P). From 2002 she has been a member of the management team of the institute.
- S.P.I. Huls, A. Sajjad, T.A. Kanters, L. Hakkaart-van Roijen, W.B.F. Brouwer & N.J.A. van Exel (2021). Tijdens lockdown maakten werkenden minder uren en kregen ze minder gedaan. Economisch-Statistische Berichten, 106 (4793), 11-13.
- M. Goorden, A. Muntingh, H.W.J. van Marwijk, P. Spinhoven, H. Ader, A. van Balkom, C. van der Feltz-Cornelis & L. Hakkaart-van Roijen (2014). Cost utility analysis of a collaborative stepped care intervention for panic and generalized anxiety disorders in primary care. Journal of Psychosomatic Research, 24 (3), 555-562. doi: 10.1016/j.jpsychores.2014.04.005
- K.M. Steenbergen-Wijenburg, L. de Vroege, R.R. Ploeger, J.W. Brals, M.G. Vloedbeld, T.F. Veneman, L. Hakkaart-van Roijen, F.F.H. Rutten, A.T.F. Beekman & C.M. van der Feltz-Cornelis (2010). Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatients clinics. Bmc Health Services Research, 10 (235), 1-14. doi: 10.1186/1472-6963-10-235
- M.M. Thunnissen, H.J. Duivenvoorden, J.J. van Busschbach, L. Hakkaart-van Roijen, W. van Tilburg, R. Verheul & W. Trijsburg (2009). De effectiviteit van re-integratietraining versus boostersessies na kortdurende klinische psychotherapie: een gerandomiseerd klinisch onderzoek. Tijdschrift voor Psychiatrie, 51, 75-86.
- L. van Roijen (2000). Werk voor alternatieve genezers. Pharmaceutisch Weekblad, 135 (9), 310-312.
- T.A. Kanters, C.L.P. Van de Ree, M.A.C. De Jongh, T. Gosens & L. Hakkaart-van Roijen (2020). Burden of illness of hip fractures in elderly Dutch patients. Archives of Osteoporosis, 15 (11). doi: 10.1007/s11657-019-0678-y
- F.C.W. van Krugten, C.M. van der Feltz-Cornelis, M.A. Boeschoten, S.A.M. Broeckhuysen-Kloth, J.F. van Eck van der Sluijs, E. van Ee, S.M. van Es, M. Schoorl, L.M. Tak, W.B.F. Brouwer & L. Hakkaart-van Roijen (2020). Development and psychometric evaluation of the Transdiagnostic Decision Tool: matched care for patients with a mental disorder in need of highly specialised care. Bjpsych Open, 6 (6). doi: 10.1192/bjo.2020.74
- V.T. Reckers - Droog, M. Goorden, Y. dr. Kaminer, L. van Domburgh, W.B.F. Brouwer & L. Hakkaart-van Roijen (2020). Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations. PLoS One (online), 15 (9), 0-10. doi: 10.1371/journal.pone.0238858
- L.W. ten Hoopen, P.F.A. de Nijs, J. Duvekot, K. Greaves-Lord, M.H.J. Hillegers, W.B.F. Brouwer & L. Hakkaart - van Roijen (2020). Children with an autism spectrum disorder and their caregivers: capturing health-related and care-related quality of life. Journal of Autism and Developmental Disorders, 49 (323), 1-15. doi: 10.1007/s10803-019-04249-w [go to publisher's site]
- F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, P. van Oppen, D.J.F. van Schaik, W.B.F. Brouwer & L. Hakkaart-van Roijen (2019). The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care. BMC Psychiatry, 19:179. doi: 10.1186/s12888-019-2165-9 [go to publisher's site]
- S.M. Mohnen, J.M.J. Oosten, J. Los, M.J.H. Leegte, K.J. Jager, M.H. Hemmelder, S.S.J. Logtenberg, V.S. Stel, L. Hakkaart - van Roijen & G.A. de WIt (2019). Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data. PLoS One (online). doi: 10.1371/journal.pone.0220800 [go to publisher's site]
- J.M.J. Oosten, S.S.J. Logtenberg, M.J.H. Leegte, H.J.G. Bilo, S.M. Mohnen, L. Hakkaart - van Roijen, M.H. Hemmelder, G.A. de WIt, K.J. Jager & V.S. Stel (2019). Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data. Nephrology Dialysis Transplantation. doi: 10.1093/ndt/gfz146
- V.T. Reckers - Droog, M. Goorden, M. Dijkgraaf, H. Van Eeren, K.E. McCollister & L. Hakkaart-van Roijen (2019). Unit Costs of Delinquent Acts for Use in Economic Evaluations. Journal of Mental Health Policy and Economics, 22 (2), 71-79.
- A. Sajjad, M.M. Versteegh, J. van Busschbach, J. Simon & L. Hakkaart-van Roijen (2019). In Search of a Pan-European Value Set; Application for Eq-5d-3l: The Pecunia Project. Value in Health, 22, S815. doi: 10.1016/j.jval.2019.09.2204
- T.A. Kanters, R. Timman, M. Zijlstra-Vlasveld, A. Muntingh, K. Huijbregts, K. van Steenbergen-Weijenburg, C.A.M. Bouwmans, C.M. van der Feltz-Cornelis & L. Hakkaart-van Roijen (2019). Assessing Costs Using the Treatment Inventory Cost in Psychiatric Patients (TIC-P), TIC-P Mini and TIC-P Midi. Journal of Mental Health Policy and Economics, 22 (1), 15-24.
- T.A. Kanters, W.K. Redekop & L. Hakkaart - van Roijen (2018). International differences in patient access to ultra-orphan drugs. Health Policy and Technology, 7, 57-64. doi: 10.1016/j.hlpt.2017.12.001
- T.A. Kanters, H.B. Thio & L. Hakkaart - van Roijen (2018). Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria. British Journal of Dermatology, 179 (3), 702-708. doi: 10.1111/bjd.16476
- P. Sinnaeve, L.M.C. Bosch, L. Hakkaart - van Roijen & S. Vansteelandt (2018). Effectiveness of step-down versus outpatient dialectical behaviour therapy for patients with severe levels of borderline personality disorder: a pragmatic randomized controlled trial. BioMed Central, 2018 (5:12), 1-10. doi: 10.1186/s40479-018-0089-5
- F.C.W. van Krugten, M. Goorden, A.J.L.M. van Balkom, J. Spijker, W.B.F. Brouwer & L. Hakkaart-van Roijen (2018). Indicators to facilitate the early identification of patients with major depressive disorder in need of highly specialized care: A concept mapping study. Depression and Anxiety, 35 (4), 346-352. doi: 10.1002/da.22741
- M. Goorden, C.M. van der Feltz-Cornelis, K.M. van Steenbergen-Weijenburg, E.K. Horn, A.T.F. Beekman & L. Hakkaart - van Roijen (2017). Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM). Neuropsychiatric Disease and Treatment, 2017:13, 1881-1893. doi: 10.2147/NDT.S134008
- A.E. Dingemans, M. Goorden, F.J.B. Lotters, C.A.M. Bouwmans - Frijters, U.N. Danner, A. van Elburg, E. Van Furth & L. Hakkaart - van Roijen (2017). Development and validation of decision tool for early identification of adult patients with severe and complex eating disorder psychopathology in need of hughly specialized care. European Eating Disorders Review. doi: 10.1002/erv.2528
- T.A. Kanters, C.A.M. Bouwmans, N. van der Linden, S.S. Tan & L. Hakkaart-van Roijen (2017). Update of the Dutch manual for costing studies in health care. PLoS One (print), 12. doi: 10.1371/journal.pone.0187477 [go to publisher's site]
- T.A. Kanters, A.T. van der Ploeg, M.E. Kruijshaar, D. Rizopoulos, W.K. Redekop, M.P.M.H. Rutten - van Molken & L. Hakkaart - van Roijen (2017). Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease. Orphanet Journal of Rare Diseases, 12:179. doi: 10.1186/s13023-017-0731-0 [go to publisher's site]
- S.J. Schawo, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). Clinicians’ Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes. Journal of Mental Health Policy and Economics, 20 (3), 131-136.
- S.J. Schawo, C.A.M. Bouwmans - Frijters, E. van der Schee, V. Hendriks, W.B.F. Brouwer & L. Hakkaart - van Roijen (2017). The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review. Health and Quality of Life Outcomes, 15:179. doi: 10.1186/s12955-017-0722-9
- F.C.W. van Krugten, M. Kaddouri, M. Goorden, A.J.L.M. van Balkom, C. Bockting, F.P.M.L. Peeters & L. Hakkaart-van Roijen (2017). Indicators of patients with major depressive disorder in need of highly specialized care: A systematic review. PLoS One (online). doi: 10.1371/journal.pone.0171659
- M.J.C. Eijkemans, F.A.M. Kersten, A. Lintsen, C. Hunault, C.A.M. Bouwmans - Frijters, L. Hakkaart - van Roijen, J.D.F. Habbema & D.D.M. Braat (2017). Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study. Human Reproduction, 32 (5), 999-1008. doi: 10.1093/humrep/dex018
- M. Goorden, S.J. Schawo, C.A.M. Bouwmans - Frijters, E. van der Schee, V. Hendriks & L. van Roijen (2016). The cost-effectiveness of family/family-based therapy for treatment of externalizing disorders, substance abuse and delinquency: A systematic review. BMC Psychiatry, 16:237. doi: 10.1186/s12888-016-0949-8
- K. Karlsdotter, C. Bushe, L. Hakkaart-van Roijen, E. Sobanski, C.C. Kan, J. Lebrec, S.A. Kraemer & N.A.H.M. Dieteren (2016). Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe. Current Medical Research & Opinion, 32 (9), 1547-1556. doi: 10.1080/03007995.2016.1189892
- H.M. Krol, J. Papenburg, S.S. Tan, W.B.F. Brouwer & L. Hakkaart-van Roijen (2016). A Noticeable Difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. European Journal of Health Economics (HEPAC), 17 (4), 391-402. doi: 10.1007/s10198-015-0685-x
- E.K. Horn, R. Verheul, M. Thunnissen, J. Delimon, M. Goorden, L. van Roijen, M. Soons, A. Meerman, U. Ziegler, B. Rossum, T. Stijnen, P.M.G. Emmelkamp & J.J.V. van Busschbach (2016). COST-EFFECTIVENESS OF SHORT-TERM INPATIENT PSYCHOTHERAPY BASED ON TRANSACTIONAL ANALYSIS IN PATIENTS WITH PERSONALITY DISORDER. Journal of Personality Disorders, 30 (4), 483-501. doi: 10.1521/pedi_2015_29_210
- M. Goorden, E. van der Schee, V.M. Hendriks & L. Hakkaart-van Roijen (2016). Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug and Alcohol Dependence, 162, 154-161. doi: 10.1016/j.drugalcdep.2016.03.004
- H. van Eeren, S.J. Schawo, R.H.J. Scholte, J.J.V. van Busschbach & L. Hakkaart-van Roijen (2015). Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration. PLoS One (print), 10 (7). doi: 10.1371/journal.pone.0131255
- T.A. Kanters, C. Wolff, D. Boyson, C. Kouakam, T. Dinh, L. Hakkaart-van Roijen & M.P.M.H. Rutten - van Molken (2015). Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vx. Reveal LINQ in a procedure room. Europace, 18 (6), 919-924. doi: 10.1093/europace/euv217 [go to publisher's site]
- M. van Agthoven, A. Kolk, H. Knegtering, P. Delespaul, J. Arends, P. Jeurissen, P.F.M. Krabbe, R. Huijsman, R. Luijk, E. de Beurs, L. Hakkaart-van Roijen & R. Bruggeman (2015). Doelmatigheid in de GGZ: toekomst dankzij ROM? Tijdschrift voor Psychiatrie, 57 (9), 672-679.
- G. Romijn, H. Riper, R. Kok, T. Donker, M. Goorden, L. Hakkaart-van Roijen, L. Kooistra, A. van Balkom & J. Koning (2015). Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized contolled trial. BioMed Central, 15 (311), 1-10. doi: 10.1186/s12888-015-0697-1
- C.A.M. Bouwmans - Frijters, C. de Sonneville-Koedoot, C.L. Mulder & L. Hakkaart-van Roijen (2015). Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 2125-2142. doi: 10.2147/NDT.S83546
- C.A.M. Boumans, H.M. Krol, J.L. Severens, M.A. Koopmanschap, W.B.F. Brouwer & L. Hakkaart-van Roijen (2015). The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in Health, 18, 753-758. doi: 10.1016/j.jval.2015.05.009
- T.A. Kanters, W.K. Redekop, M.P.M.H. Rutten - van Molken, M.E. Kruijshaar, D. Güngör, A.T. van der Ploeg & L. Hakkaart-van Roijen (2015). A conceptual disease model for adult Pompe disease. Orphanet Journal of Rare Diseases, 10:112. doi: 10.1186/s13023-015-0334-6
- R. Timman, C.A.M. Bouwmans - Frijters, J.J.V. van Busschbach & L. Hakkaart - van Roijen (2015). Development of the Treatment Inventory of Costs in Psychiatric Patients: TIC-P Mini and Midi. Value in Health, 18 (8), 994-999. doi: 10.1016/j.jval.2015.07.006
- T.A. Kanters, L. Hakkaart-van Roijen, M.P.M.H. Rutten - van Molken & W.K. Redekop (2015). Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug? Expert review of pharmacoeconomics & outcomes research, 15 (4), 557-559. doi: 10.1586/14737167.2015.1045882
- A. van der Kolk, C.A.M. Boumans, S.J. Schawo, J.K. Buitelaar, M. van Agthoven & L. Hakkaart-van Roijen (2015). Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands. SpringerPlus, 4, 224. doi: 10.1186/s40064-015-0978-7
- A. Kolk, M. van Agthoven, J.K. Buitelaar & L. Hakkaart-van Roijen (2015). A Systematic Review of Literatures on Factors Associated with Educational and Academic Performance in Attention DeficitHyperactivity Disorder. Creative Education, 6, 164-180. doi: 10.4236/ce.2015.62015 [go to publisher's site]
- S.J. Schawo, A. van der Kolk, C.A.M. Boumans, L. Annemans, M.J. Postma, J. Buitelaar, M. van Agthoven & L. Hakkaart-van Roijen (2015). Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed? Pharmacoeconomics (Online), 33, 489-509. doi: 10.1007/s40273-015-0259-x [go to publisher's site]
- T.A. Kanters, W.K. Redekop, M.E. Kruijshaar, A.T. van der Ploeg, M.P.M.H. Rutten - van Molken & L. Hakkaart-van Roijen (2015). Comparison of EQ-5D and SF-6D utilities in Pompe disease. Quality of Life Research, 24, 837-844. doi: 10.1007/s11136-014-0833-2
- T.A. Kanters, I. Hoogenboom-Plug, M.P.M.H. Rutten - van Molken, W.K. Redekop, A.T. van der Ploeg & L. Hakkaart-van Roijen (2014). Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease. Orphanet Journal of Rare Diseases, 9, 75. doi: 10.1186/1750-1172-9-75
- M. Goorden, M.C. Vlasveld, J.R. Anema, W. van Mechelen, A. Beekman, R. Hoedeman, C.M. van der Feltz-Cornelis & L. Hakkaart-van Roijen (2014). Cost-Utility Analysis of a Collaborative Care Intervention for Major Depressive Disorder in an Occupational Healthcare Setting. Journal of Occupational Rehabilitation, 24 (3), 555-562. doi: 10.1007/s10926-013-9483-4
- E.L. Noordraven, C. Audier, A.B.P. Staring, A.I. Wierdsma, P. Blanken, B. van der Hoorn, L. Hakkaart-van Roijen & C.L. Mulder (2014). Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders. BMC Psychiatry, 14, 343-353. doi: 10.1186/s12888-014-0343-3
- K. de Jong, R. Timman, L. Hakkaart-van Roijen, P. Vermeulen, C.G. Kooiman, J. Passchier & J. van Busschbach (2014). The effect of outcome monitoring feedback to clinicians and patients in short and long-term psychotherapy: A randomized controlled trial. Psychotherapy Research, 24 (6), 629-639. doi: 10.1080/10503307.2013.871079
- K.G. Reeuwijk, S. Robroek, L. Hakkaart-van Roijen & A. Burdorf (2014). How Work Impairments and Reduced Work Ability are Associated with Health Care Use in Workers with Musculoskeletal Disorders, Cardiovascular Disorders or Mental Disorders. Journal of Occupational Rehabilitation, 24 (4), 631-639. doi: 10.1007/s10926-013-9492-3
- A. van der Kolk, C.A.M. Boumans, S.J. Schawo, J.K. Buitelaar, M. van Agthoven & L. Hakkaart-van Roijen (2014). Association between quality of life and treatment response in children with attention deficit hyperactivity disorder and their parents. The Journal of Mental Health Policy and Economics, 17 (3), 119-129.
- N.J. Elbert, H. van Os-Medendorp, W. van Renselaar, A. Ekeland, L. Hakkaart-van Roijen, H. Raat, T.E.C. Nijsten & S.G.M.A. Pasmans (2014). Effectiveness and Cost-Effectiveness of eHealth Interventions in Somatic Diseases: A Systematic Review of Systematic Reviews and Meta-Analyses. Journal of Medical Internet Research, 16 (4), 182-204. doi: 10.2196/jmir.2790
- S.S. Tan, A. Geissler, L. Serden, M. Heurgren, B.M. van Ineveld, W.K. Redekop & L. Hakkaart-van Roijen (2014). DRG systems in Europe: variations in cost accounting systems among 12 countries. European Journal of Public Health, 24 (6), 1023-1028. doi: 10.1093 [go to publisher's site]
- A.L. Vataire, S. Aballea, F. Antonanzas, L. Hakkaart-van Roijen, R.W. Lam, P. McCrone, U. Persson & M. Toumi (2014). Core discrete event simulation model for the evaluation of health care technologies in major depressive disorder. Value in Health, 17 (2), 183-195. doi: 10.1016/j.jval.2013.11.012
- C.A.M. Boumans, P. Vemer, A. van Straten, S.S. Tan, F.F.H. Rutten & L. Hakkaart-van Roijen (2014). Health Related Quality-of-Life and productivity-losses in patients with depression and anxiety disorders. Journal of Occupational and Environmental Medicine, 56 (4), 420-424. doi: 10.1097/JOM.0000000000000112
- L.M.C. v.d. Bosch, P. Sinnaeve, L. Hakkaart-van Roijen & E. Van Furth (2014). Efficacy and cost-effectiveness of an experimental short-term inpatient Dialetical Behavior Therapy (DBT) program. BioMed Central, 15 (152), 1-9. doi: 10.1186/1745-6215-15-152
- T.A. Kanters, A. Steenhoek & L. Hakkaart-van Roijen (2014). Orphan drugs expenditure in the Netherlands in the period 2006-2012. Orphanet Journal of Rare Diseases, 9:154. doi: 10.1186/s13023-014-0154-0
- T.A. Kanters, C. de Sonneville-Koedoot, W.K. Redekop & L. Hakkaart-van Roijen (2013). Systematic review of available evidence on 11 high-priced inpatient orphan drugs. Orphanet Journal of Rare Diseases, 8. doi: 10.1186/1750-1172-8-124
- C.A.M. Boumans, A. van der Kolk, M. Oppe, S.J. Schawo, E.A. Stolk, M. van Agthoven, J.K. Buitelaar & L. Hakkaart-van Roijen (2013). Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD. The European Journal Of Health Economics. doi: 10.1007/s10198-013-0540-x
- T.A. Kanters, I. Plug, M.P.M.H. van Molken, W.K. Redekop, A.T. van der Ploeg & L. Hakkaart-van Roijen (2013). Cost-effectiveness of enzyme replacement therapy (ERT) with alglucosidase alfa in classic-infantile patients with Pompe disease. Value in Health, 16 (7), A384-A384. doi: 10.1016/j.jval.2013.08.353
- E.W. de Heer, J. Dekker, J.F. van Eck van der Sluijs, A.T.F. Beekman, H.W.J. van Marwijk, T.J. Holwerda, P.M. Bet, J. Roth, L. Hakkaart-van Roijen, L. Ringoir, F. Kat & C.M. van der Feltz-Cornelis (2013). Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled multi-Centre trial: TCC:PAINDIP. BMC Psychiatry, 13 (1), 147. doi: 10.1186/1471-244X-13-147
- P. Vemer, C.A.M. Boumans, M. Zijlstra-Vlasveld, C.M. van der Feltz-Cornelis & L. Hakkaart-van Roijen (2013). Let's go back to work: survival analysis on the return-to-work after depression. Neuropsychiatric Disease and Treatment, 9, 1637-1645. doi: 10.2147/NDT.S49883
- J.J. Aardoom, A.E. Dingemans, P. Spinhoven, L. Hakkaart-van Roijen & E.F. van Furth (2013). An Internet-based intervention for eating disorders consisting of automated computer-tailored feedback with or without supplemented frequent or infrequent support from a coach: study protocol for a randomized controlled trial. Trials, 14 (340). doi: 10.1186/1745-6215-14-340
- T.A. Kanters, A.T. van der Ploeg, M.P.M.H. Rutten - van Molken & L. Hakkaart-van Roijen (2013). Vergoeding duur middel vraagt breder fundament. Medisch Contact, 68 (42), 2150-2153.
- T.A. Kanters, A.T. van der Ploeg, W.B.F. Brouwer & L. Hakkaart-van Roijen (2013). The impact of informal care for patients with Pompe disease: An application of the CarerQol instrument. Molecular Genetics and Metabolism, 110 (3), 281-286. doi: 10.1016/j.ymgme.2013.07.020
- C.A.M. Boumans, K. de Jong, R. Timman, M. Zijlstra-Vlasveld, C. Van der Feltz-Cornelis, S.S. Tan & L. Hakkaart-van Roijen (2013). Feasibility, reliability and validity of a questionnaire on health care consumption and productivity loss in patients with a psychiatric disorder (TiC-P). Bmc Health Services Research, 13 (1):217. doi: 10.1186/1472-6963-13-217
- L. Hakkaart-van Roijen, T.J.E.M. Bakker, M.J. Al, J. van der Lee, H.J. Duivenvoorden, M.W. Ribbe & R. Huijsman (2013). Economic evaluation alongside a single RCT of an integrative psychotherapeutic nursing home programme. Bmc Health Services Research, 13 (370), 1-13. doi: 10.1186/1472-6963-13-370
- D. Volker, M.C. Vlasveld, J.R. Anema, A.T.F. Beekman, L. Hakkaart-van Roijen, E.P.M. Brouwers, A. van Lomwel & C.M. van der Feltz-Cornelis (2013). Blended E-health module on return to work embedded in collaborative occupational health care for common mental disorders: design of a cluster randomized controlled trial. Neuropsychiatric Disease and Treatment, 9, 529-537. doi: 10.2147/NDT.S43969
- S.S. Tan, L. Hakkaart-van Roijen, B.M. van Ineveld & W.K. Redekop (2013). Explaining length of stay variation of episodes of care in the Netherlands. European Journal of Health Economics (HEPAC), 14, 919-927. doi: 10.1007/s10198-012-0436-1
- S.J. Schawo, H. van Eeren, D.I. Soeteman, M.C. van der Veldt, M.J. Noom, W.B.F. Brouwer, J.J. van Busschbach & L. Hakkaart-van Roijen (2012). Framework for Modelling the Cost-effectiveness of Systemic Interventions Aimed to Reduce Youth Delinquency. The Journal of Mental Health Policy and Economics, 15, 187-196.
- K.M.L. Huijbregts, F.J. de Jong, H.W.J. van Marwijk, A.T.F. Beekman, H.J. Adèr, L. Hakkaart-van Roijen, J. Unutzer & C.M. van der Feltz-Cornelis (2012). A target-driven collaborative care model for Major Depressive Disorder is effective in primary care in the Netherlands. A randomized clinical trial from the depression initiative. Journal of Affective Disorders. doi: 10.1016/j.jad.2012.09.015
- S.S. Tan, C.A.M. Boumans & L. Hakkaart-van Roijen (2012). Handleiding voor kostenonderzoek methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg. TSG, 90, 367-372.
- L. Hakkaart-van Roijen & S.S. Tan (2012). Doelmatigheidsonderzoek in de jeugd-GGZ: op weg naar volwassenheid. Kinder- en jeugdpsychotherapie, 39 (1), 39-46.
- S.S. Tan, C.A.M. Boumans, F.F.H. Rutten & L. Hakkaart-van Roijen (2012). Update of the Dutch Manual for costing in economic evaluations. International Journal of Technology Assessment in Health Care, 28 (2), 152-158. doi: 10.1017/S0266462312000062
- S.S. Tan, J. Bakker, M.E. Hoogendoorn, A. Kapila, J.J. Martin, A. Pezzi, G. Pittoni, P.E. Spronk, R. Welte & L. Hakkaart-van Roijen (2012). Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology. Value in Health, 15, 81-86. doi: 10.1016/j.jval.2011.09.007
- A. van der Lee, T. Stoop, P.J.A. Stam, L. Hakkaart-van Roijen & J. Van Busschbach (2012). Vergoedingsaspecten: kunnen stagering en profilering ervoor zorgen dat de juiste zorg ook juist beloond wordt? Tijdschrift voor Psychiatrie, 54 (11), 985-989.
- S.S. Tan, F.F.H. Rutten & L. Hakkaart-van Roijen (2011). Incorporation of economic evidence in the Dutch guideline 'cardiovascular risk management'. Journal of Evaluation in Clinical Practice, 17, 1094-1101. doi: 10.1111/j.1365-2753.2010.01481.x
- S.S. Tan, E. van der Putten, W.M. Nijdam, P. Hanssens, G. Beute, P.J.C.M. Nowak, C.M.F. Dirven & L. Hakkaart-van Roijen (2011). A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients. Journal of Neuro-Oncology, 101 (2), 237-245. doi: 10.1007/s11060-010-0243-4
- K.M. van Steenbergen-Weijenburg, A.L. van Puffelen, E.K. Horn, J. Nuyen, P.S. van Dam, T.B. van Benthem, A.T.F. Beekman, F.F.H. Rutten, L. Hakkaart-van Roijen & C.M. van der Feltz-Cornelis (2011). More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic. Diabetic Medicine, 28, 86-89. doi: 10.1111/j.1464-5491.2010.03125.x
- L. Hakkaart-van Roijen, W. Goettsch, M. Ekkebus, P. Gerretsen & E.A. Stolk (2011). The Cost-Effectiveness of an Intensive Treatment Protocol for Severe Dyslexia in Children. Dyslexia, 17 (3), 256-267. doi: 10.1002/dys.436
- K.M. van Steenbergen-Weijenburg, L. de Vroege, R.R. Ploeger, J.W. Brals, M.G. Vloedbeld, T.F. Veneman, L. Hakkaart-van Roijen, F.F.H. Rutten, A.T.F. Beekman & C.M. van der Feltz-Cornelis (2011). Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. Bmc Health Services Research, 235 (10), 1-6.
- T.A. Kanters, M.L.C. Hagemans, N.A.M.E. van der Beek, F.F.H. Rutten, A.T. van der Ploeg & L. Hakkaart-van Roijen (2011). Burden of illness of Pompe disease in patients only receiving supportive care. Journal of Inherited Metabolic Disease, 34, 1045-1052. doi: 10.1007/s10545-011-9320-x
- M.J. Al, L. Hakkaart-van Roijen, S.S. Tan & J. Bakker (2010). Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Critical Care, 14 (195), 1-10. doi: 10.1186/cc9313
- C.C. Berghout, J. Zevalkink & L. Hakkaart-van Roijen (2010). The Effects of Long-Term Psychoanalytic Treatment on Healthcare Utilization and Work Impairment and Their Associated Costs. Journal of Psychiatric Practice, 16 (4), 209-216. doi: 10.1097/01.pra.0000386907.99536.75
- C.C. Berghout, J. Zevalkink & L. Hakkaart-van Roijen (2010). A cost-utility analysis of psychoanalysis versus psychoanalytic psychotherapy. International Journal of Technology Assessment in Health Care, 26 (1), 3-10. doi: 10.1017/S0266462309990791
- S.S. Tan, C.W.M. van Gils, M.G. Franken, L. Hakkaart-van Roijen & C.A. de Uyl-de Groot (2010). The Unit Costs of Inpatient Hospital Days, Outpatient Visits and Daycare Treatments in the Fields of Oncology and Hematology. Value in Health, 13 (6), 712-719. doi: 10.1111/j.1524-4733.2010.00740.x
- K.M. van Steenbergen-Weijenburg, C.M. van der Feltz-Cornelis, E.K. Horn, H.W.J. van Marwijk, A.T.F. Beekman, F.F.H. Rutten & L. Hakkaart-van Roijen (2010). Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review. Bmc Health Services Research, 10 (19), 1-10. doi: 10.1186/1472-6963-10-19
- L. Hakkaart-van Roijen, S.S. Tan, L.M.A. Goossens, S.J. Schawo, W.B.F. Brouwer, M.P.M.H. Rutten - van Molken & F.F.H. Rutten (2010). Doelmatigheid in praktijkrichtlijnen voor medicijnen: resultaten van een 'quick scan'. TSG, 4 (88), 175-181.
- S.S. Tan, M. Oppe, S.K. Zoet-Nugteren, R.A. Niezen, M.J.M. Kofflard, F.J. ten Cate & L. Hakkaart-van Roijen (2009). A microcosting study of diagnostic tests for the detection of coronary artery disease in the Netherlands. European Journal of Radiology, 72 (1), 98-103. doi: 10.1016/j.ejrad.2008.07.002
- S.S. Tan, F.F.H. Rutten, B.M. van Ineveld, W.K. Redekop & L. Hakkaart-van Roijen (2009). Comparing methodologies for the cost estimation of hospital services. European Journal of Health Economics (HEPAC), 10, 39-45. doi: 10.1007/s10198-008-0101-x
- L. Hakkaart-van Roijen, P. Verboom, R. Philips & M.J. Al (2009). The cost utility of solifenacin in the threatment of overactive bladder. International Urology and Nephrology, 41, 293-298. doi: 10.1007/s11255-008-9448-2
- S.S. Tan, B.M. van Ineveld, W.K. Redekop & L. Hakkaart-van Roijen (2009). Comparing Methodologies for the Allocation of Overhead and Capital Costs to Hospital Services. Value in Health, 12 (4), 530-535. doi: 10.1111/j.1524-4733.2008.00475.x
- M. Thunnissen, H. Duivenvoorden, J. van Busschbach, L. van Roijen, W. van Tilburg, R. Verheul & W. Trijsburg (2008). A randomized clinical trial on the effectiveness of a reintegration training program versus booster sessions after short-term inpatient psychotherapy. Journal of Personality Disorders, 22 (5), 483-495. doi: 10.1521/pedi.2008.22.5.483
- C.A.M. Boumans, A. Lintsen, M.J. Al, C. Verhaak, M.J.C. Eijkemans, J.D.F. Habbema, D.D.M. Braat & L. Hakkaart-van Roijen (2008). Absence from work and emotional stress in woman undergoing IVF or ICSI: An analysis of IVF-related absence from work in women and the contribution of general and emotional factors. Acta Obstetricia et Gynecologica Scandinavica, 87, 1169-1175. doi: 10.1080/00016340802460305
- D.I. Soeteman, L. van Roijen, R. Verheul & J.J.V. van Busschbach (2008). The economic burden of personality disorders in mental health care. Journal of Clinical Psychiatry, 69 (2), 259-265.
- J.J. Kerremans, P. Verboom, T. Stijnen, L. Hakkaart-van Roijen, W. Goessens, H.A. Verbrugh & M.C. Vos (2008). Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. Journal of Antimicrobial Chemotherapy. doi: 10.1093/jac/dkm497
- S.S. Tan, L. Hakkaart-van Roijen, M.J. Al, C.A.M. Boumans, M.E. Hoogendoorn, P.E. Spronk & J. Bakker (2008). A microcosting study of intensive care unit stay in the Netherlands. Journal of Intensive Care Medicine, 23 (4), 250-257. doi: 10.1177/0885066608318661
- M.J.C. Eijkemans, A. Lintsen, C.C. Hunault, C.A.M. Boumans, L. Hakkaart-van Roijen, D.D.M. Braat & J.D.F. Habbema (2008). Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study. Human Reproduction, 23 (7), 1627-1632. doi: 10.1093/humrep/den132
- D.I. Soeteman, L. Hakkaart-van Roijen, R. Verheul & J.J. van Busschbach (2007). The economic burden of personality disorders. Journal of Mental Health Policy and Economics, 10, 42.
- A. Lintsen, M.J.C. Eijkemans, C.C. Hunault, C.A.M. Boumans, L. Hakkaart-van Roijen, J.D.F. Habbema & D.D.M. Braat (2007). Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Human Reproduction, 22 (9), 2455-2462. doi: 10.1093/humrep/dem183
- L. Hakkaart-van Roijen, B.W.C. Zwirs, C.A.M. Boumans, S.S. Tan, T.W.J. Schulpen, L. Vlasveld & J.K. Buitelaar (2007). Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). European Child & Adolescent Psychiatry, 16 (5), 316-326. doi: 10.1007/s00787-007-0603-6
- M.A. Ijff, K.M.L. Huijbregts, H.W.J. van Marwijk, A. Beekman, L. Hakkaart-van Roijen, F.F.H. Rutten, J. Unutzer & C.M. van der Feltz-Cornelis (2007). Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomiese clinical trial. Bmc Health Services Research, 7 (34), 1-11. doi: 10.1186/1472-6963-7-34
- E.K. Horn, T.B. van Benthem, L. Hakkaart-van Roijen, H.W.J. van Marwijk, A. Beekman, F.F.H. Rutten & C.M. van der Feltz-Cornelis (2007). Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting a randomised controlled trial. Bmc Health Services Research, 7 (28), 1-14. doi: 10.1186/1472-6963-7-28
- L. Lamers, C.A.M. Boumans, A. van Straten, M.C.H. Donker & L. Hakkaart-van Roijen (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15, 1229-1236. doi: 10.1002/hec.1125
- L. Hakkaart-van Roijen, A. van Straten, A. Maiwenn, F.F.H. Rutten & M. Donker (2006). Cost-utility of brief psychological treatment for depression and anxiety. British Journal of Psychiatry, 188, 323-329.
- M.A. Koopmanschap, W.B.F. Brouwer, L. van Roijen & N.J.A. van Exel (2005). Influence of waiting time on cost-effectiveness. Social Science & Medicine, 60 (11), 2501-2504. doi: 10.1016/j.socscimed.2004.11.022
- L. Hakkaart-van Roijen, A.W. Moll van Charante, P.J. Bindels, C.J. Yzermans & F.F.H. Rutten (2004). A cost study of a general practitioner hospital in the Netherlands. European Journal of General Practice, 10, 45-49.
- E.J. Regeer, M. ten Have, M.L. Rosso & L. van Roijen (2004). Prevalence of bipolar disorder in the general population: a reappraisal study of the Netherlands mental health survey. Acta Psychiatrica Scandinavica, 110, 374-382. doi: 10.1111/j.1600-0447.2004.00363.x
- L. van Roijen, M.B. Hoeijenbos & E.J. Regeer (2004). The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatrica Scandinavica, 110, 383-392. doi: 10.1111/j.1600-0447.2004.00403.x
- P. Verboom, L. Hakkaart-van Roijen, M.C.J.M. Sturkenboom, R. de Zeeuw, H.E. Menke & F.F.H. Rutten (2002). Epidemiology and Health services research. The cost of atopic dermatitis in the Netherlands: an international comparison. British Journal of Dermatology, 147, 716-724.
- L. Hakkaart-van Roijen, P. Verboom, W.K. Redekop, C.R. Touw & F.F.H. Rutten (2001). The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis. Pharmacoeconomics (Print), 19, 599-608.
- C.R. Touw, L. Hakkaart-van Roijen, P. Verboom, C. Paul & F.F.H. Rutten (2001). Finlay a quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. British Journal of Dermatology, 144, 967-972.
- C. Ehrnborg, L. van Roijen, B. Jonsson, F.F.H. Rutten, B.A. Bengtsson & T. Rosén (2000). Cost of illness in adult patients with hypopituitarism. Pharmacoeconomics (Print), 17 (6), 621-628.
- Q.D. van Dam, A. van t Spijker, L.R. Arends, L. Hakkaart-van Roijen, M.C.H. Donker & R.W. Trijsburg (1998). Doelmatigheid van psychotherapie: een haalbaarheidsonderzoek. Tijdschrift voor Psychotherapie, 24 (1), 5-22.
- L. van Roijen, A. Beckers, A. Stevenaert & F.F.H. Rutten (1998). The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency. Pharmacoeconomics (Print), 14 (4), 395-403. doi: 10.2165/00019053-199814040-00006
- L. van Roijen & F.F.H. Rutten (1997). 'Kosten van ziekte' -studies: beleidsrelevantie en methoden. Tijdschrift voor Sociale Gezondheidszorg, 75 (4), 184-188.
- M.A. Koopmanschap, F.F.H. Rutten, B.M. van Ineveld & L. van Roijen (1997). Reply to Johanneson's and Karlsson's comment. Journal of Health Economics, 257-259.
- L. van Roijen, A. Beckers, A. Stevenaert, J.J. van Busschbach, W. van Eijk & F.F.H. Rutten (1997). The burden of hypopituitarism in adults after pituitary surgery. Endocrinology & Metabolism, 139-142.
- L. van Roijen, H.G.T. Nijs, C.J.J. Avezaat, G. Karlsson, C. Linquist, K.H. Pauw & F.F.H. Rutten (1997). Costs and effects of microsurgery versus radiosurgery in treating acoustic neuroma. Acta Neurochirurgica, 942-948. doi: 10.1007/BF01411303
- E.F. van Beeck, L. van Roijen & J.P. Mackenbach (1997). Medical costs and economic production losses due to injuries in the Netherlands. Journal of Trauma-Injury Infection and Critical Care, 42 (6), 1116-1123. doi: 10.1097/00005373-199706000-00023
- L. van Roijen, M.L. Bot, M.A. Koopmanschap, G.J. Bonsel & F.F.H. Rutten (1996). Labor and Health Status in Economic Evaluation of Health Care. International Journal of Technology Assessment in Health Care, 12 (3), 405-415.
- L. van Roijen, M.L. Essink-Bot, M.A. Koopmanschap, B.C. Michel & F.F.H. Rutten (1995). Societal Perspective on the Burden of Migraine in The Netherlands. Pharmacoeconomics (Print), 7 (2), 170-179.
- L. van Roijen, M.A. Koopmanschap, F.F.H. Rutten & P.J. van der Maas (1995). Indirect costs of disease; an international comparison. Health Policy, 33, 15-29. doi: 10.1016/0168-8510(94)00704-I
- M.A. Koopmanschap, F.F.H. Rutten, B.M. van Ineveld & L. van Roijen (1995). The friction cost method for measuring indirect costs of disease. Journal of Health Economics, 14, 171-189. doi: 10.1016/0167-6296(94)00044-5
- M.L. Essink-Bot, L. van Roijen, P.F.M. Krabbe, G.J. Bonsel & F.F.H. Rutten (1995). The Impact of Migraine on Health Status. Headache, 35 (april), 200-206.
- L. van Roijen & J.F. Wunderink (1994). De verdeling van huishoudelijk werk en vrije tijd. Economisch-Statistische Berichten, 78, 365-368.
- L. Hakkaart-van Roijen, D.I. Soeteman & J.J. van Busschbach (2008). Kosteneffectiviteit. In Multidisciplinaire richtlijn persoonlijkheidsstoornissen 2008. Utrecht: Trimbos instituut
- M. Goorden & L. Hakkaart-van Roijen (2013). Doelmatigheidsonderzoek in de ggz. In Handboek sociale psychiatrie (pp. 41-52). Utrecht: De Tijdstroom
- S.S. Tan, L. Serden, A. Geissler, B.M. van Ineveld, W.K. Redekop, M. Heurgren & L. Hakkaart-van Roijen (2011). DRGs and cost accounting: Which is driving which? In R. Busse, A. Geissler, W. Quentin & M. Wiley (Eds.), Diagnosis - Related Groups in Europe (pp. 61/5-74/5). Berkshire, England: Open University Press
- S.S. Tan, B.M. van Ineveld, W.K. Redekop & L. Hakkaart-van Roijen (2011). The Netherlands: The Diagnose Behandeling Combinaties. In R. Busse, A. Geissler, W. Quentin & M. Wiley (Eds.), Diagnosis - Related Groups in Europe (pp. 425/23-446/23). Berkshire, England: Open University Press
- T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Extern rapport). Rotterdam: Instituut Beleid & Management Gezondheidszorg
- T. Zuiderent, S. Jerak, H.M. van de Bovenkamp, S.S. Tan, L. Hakkaart-van Roijen, W.B.F. Brouwer & R.A. Bal (2011). Variatie in richtlijnen. Wat is het probleem? (Intern rapport). Rotterdam: iBMG
- N. van der Roer, J.J. van Busschbach, E.S. Goes, L. Hakkaart-van Roijen & W.K. Redekop (2001). Kosten van de ziekte van Alzheimer; een studie naar de belangrijkste kostenposten voor patiënten met de ziekte van Alzheimer in Nederland en in Frankrijk. (Intern rapport, no 01.56). :
- R.W. Trijsburg, F. Beenen, R. van Dyck, L. Hakkaart-van Roijen, R.C. van der Mast, L. de Nobel, S. Schagen & P. Spinhoven (2001). Doelmatigheid van langdurige psychotherapie. (Extern rapport). Den Haag: Gezondheidsraad
- L. Hakkaart-van Roijen & M.L. Bot (1999). Handleiding vragenlijst over ziekte en werk. (Intern rapport, Institute for Medical Technology Assessment). :
- M.C.H. Donker, L.A.P. Arends, A. van Gageldonk, L. van Roijen, F. Smit & R. Bijl (1996). Prioriteiten voor kosteneffectiviteitsonderzoek in de GGZ. (Extern rapport). Utrecht: NcGv
- J.P. Postma, A. van Dongen - Leunis, L. Hakkaart - van Roijen & R.A. Bal (2018). Eindrapportage experiment Topzorg. (Extern rapport). Rotterdam: Erasmus School of Health Policy and Management
- J.P. Postma, A. van Dongen - Leunis, L. Hakkaart - van Roijen & R.A. Bal (2016). Tussenrapportage TopZorg. (Extern rapport). Rotterdam: institute of Health Policy and Management
- L. van Roijen (1998). Societal perspective on the cost of illness. (Intern rapport). :
- L. van Roijen (2002, januari 1). De maatschappelijke gevolgen van migraine2002. De Medische Knipselkrant, pp. 1-1.
- S.J. Schawo (2019, december 20). Economic Evaluation of Treatment for Externalizing Disorders in Adolescents -Connecting mental health and economics. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. L. Hakkaart-van Roijen.
- M. Goorden (2018, september 20). Cost-Utility of Collaboration Models in Mental Health Care. EUR Prom./coprom.: prof.dr. C.A. de Uyl-de Groot, C.M. van der Feltz-Cornelis & dr. L. Hakkaart-van Roijen.
- T.A. Kanters (2016, december 8). Health Technology Assessment Of Orphan Drugs : The example of Pompe disease. EUR Prom./coprom.: prof.dr. M.P.M.H. Rutten - van Molken, Prof. Dr. A.T. van der Ploeg & dr. L. Hakkaart-van Roijen.
- S.S. Tan (2009, november 27). Microcosting in Economic Evaluations. EUR (219 pag.) (Rotterdam: Optima Grafische Communicate) Prom./coprom.: prof.dr. C.A. de Uyl-de Groot & dr. L. Hakkaart-van Roijen.
Master Eu-HEM 2020-2021
- Title
- Master Eu-HEM 2020-2021
- Year
- 2020
Master Thesis HE
- Title
- Master Thesis HE
- Year
- 2020
- Year level
- master, master
Master HEPL-HE 2020-2021
- Title
- Master HEPL-HE 2020-2021
- Year
- 2020
Master Thesis HEPL
- Title
- Master Thesis HEPL
- Year
- 2020
- Year level
- master
Master Thesis Eu-HEM
- Title
- Master Thesis Eu-HEM
- Year
- 2020
- Year level
- master
Associate Professor
- University
- Erasmus University Rotterdam
- School
- Erasmus School of Health Policy & Management
- Department
- Health Technology Assessment (HTA)
- Country
- The Netherlands
- Telephone
- 0104088567
